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Abstract 
BACKGROUND: The most widely used tumour markers, especially in colorectal malignancy, is Carcinoembryonic 
antigen (CEA).  
AIM: This study was aimed to investigate CEA value among the degree of differentiation and tumour location.  
METHODS: A cross-sectional analytical study was used in this study on eighty consecutive patients with 
colorectal carcinoma (CRC) at Adam Malik General Hospital and Permata Bunda Hospital, Medan, Indonesia. All 
data were analysed using SPSS for Windows version 21.  
RESULTS: They were rectal cancer 49.4%, left-sided colon cancer 43.2% and right-sided colon cancer 6.2%. 
Histopathology findings were well-differentiated 40.7%, moderate differentiated 32.1% and poorly differentiated 
25.9%. There were no correlations between CEA level and haemoglobin level, white blood cells count, and 
platelet count. There was no significant difference between CEA and location of the tumour (p = 0.70), although 
CEA level was significantly differenced among histopathology findings (p = 0.03). CEA levels were and associated 
with the degree of differentiation. 
CONCLUSION: CEA levels increased in well-differentiated colorectal carcinoma especially in rectal cancer. 
 
  
 
 
 
 
 
Introduction 
 
Cancer is a disease characterized by the 
unchecked division and survival of abnormal cells. 
When this abnormal growth occurs in colon or rectum, 
it is called colorectal cancer (CRC) [1]. CRC is one of 
the common tumour types in the world, which 
accounts for 400 000 deaths annually [2]. The 
incidence rates of CRC were 19.1 for men and 15.6 
for women per 100.000 populations in Indonesia [3] 
with a major risk factor for CRC are smoking, 
alcoholism, physical inactivity and obesity [4]. 
In 1965 Gold and Freedman demonstrated 
that a CEA presents in extracts of tumours from the 
gastrointestinal tract and fetal gut tissues but not in 
extracts of adult intestinal tissues. CEA modulates 
intercellular adhesion of colon epithelial cell-collagen 
interactions. Since high concentrations of CEA 
presents in fetal tissues and tumours, it disrupts 
normal intercellular or cell-collagen adhesion forces 
allowing more cell movement and the development of 
less ordered tissues architecture and greater cell-cell 
interaction. CEA appears to have the greatest clinical 
use as evaluation of treatment efficacy and in follow-
up for recurrent disease. 
Carcinoembryonic antigen (CEA) is the most 
commonly used tumour marker for CRC diagnosis, 
prognosis evaluation or after treatment recurrence [5]. 
CEA is found in normal fetal gastrointestinal tissue 
and at very low concentrations in adult blood plasma. 
Its concentration increases in many tumours, such as 
CRC. Increased CEA concentrations were also 
reported in gastric, bronchial, uterine and ovarian 
cancers, and lymphomas as well [6].
 
American Society of Clinical Oncology 
(ASCO) defined right-sided colon cancer of cecum 
and ascending colon up to the hepatic flexure. Left-
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sided colon cancer comprises of cancers in splenic 
flexure and regions distal to the splenic flexure, 
including the rectum. The transverse colon connects 
left and right-sides and on average is appreciably 
shorter than the right and left-sides. Colorectal 
adenocarcinoma can be divided into three distinct 
disease entities: right colon cancer, left colon cancer 
and rectal cancer [3]. 
High CEA production by tumours is 
associated with increased tumour growth and poorer 
prognosis [2], [3]. CEA can be detected and 
quantitatively measured in the serum and the tumour 
tissues of CRC patients although its role in the 
prognosis of CRC (Figure 1) remains controversial [7]. 
 
Figure 1. Colorectal Cancer Incidence, 2012 
 
Current ASCO guidelines recommend that 
CEA examinations be routinely obtained at 3-month 
intervals during postoperative surveillance and at 1–3-
month intervals during systemic treatment for 
metastatic CRC [2].  
Normal value of CEA is 5 ng/mL in serum. 
Patients with appropriate symptoms, a highly 
increased concentration (e.g., 5 times the upper limit 
of normal reference value) should be considered 
strongly suggestive for the presence of cancer in that 
particular patient.  
Factors affecting serum CEA levels in patients 
with CRC are tumour stage, tumour grade, liver 
status, tumour site within colon, presence or absence 
of bowel obstruction, smoking, ploidy status of the 
tumour. Well-differentiated CRC produces higher CEA 
level than poorly differentiated one. Certain benign 
liver diseases impair liver function and, thus, CEA 
clearance. Consequently, CEA increased in serum of 
patients with nonmalignant liver diseases. Smoking 
appears to double CEA serum concentration [6]. 
Material and Methods 
 
Serum CEA levels in CRC patients were 
measured using CEA Elecsys analysers (Roche 
Diagnostics GmbH, United States) with a reference 
range of 5.0 ng/mL. CRC patients were then divided 
into two groups, those with normal serum CEA levels 
(e.g., ≤ 5 ng/mL) and those with elevated serum CEA 
levels (> 5 ng/mL) 
A cross-sectional analytical study was used in 
this study on eighty consecutive patients with CRC at 
Adam Malik General Hospital and Permata Bunda 
Hospital, Medan, Indonesia. All data were analysed 
with SPSS for Windows version 21. Data were 
examined using the Kruskal Wallis test. 
 
 
Results  
 
Demographic characteristics of the patient are 
shown in Table 1. The recruited patients consisted of 
48 males (60%), and 32 females (40%). The median 
age of these patients was 53 (25-80) years old. The 
majority of patients’ education level was senior high 
school (43.2%), elementary school (25.9%), university 
(16%) and junior high school (13.6%).  
The most common tumor location were rectal 
cancer (49.4%), left-sided colon cancer (43.2%) and 
right-sided colon cancer (6.2%). Histopathology 
examinations showed well-differentiated 41,3%, 
moderate differentiated 32.1% and poorly 
differentiated 25.9% CRCs.  
Table 1. Demographic and clinical characteristics of the 
patients 
Variable N = 80 
Gender  
Male 
Female 
 
48 (60%)a 
32 (40%)a 
Age 53 (25-80)b 
education level  
Elementary School 
Junior High School  
Senior High School 
University 
 
21 (26.3%)a 
11 (13.8%)a 
35 (43.8%)a 
13 (16.3%)a 
Tumour Location 
Rectal cancer 
Left-sided colon cancer 
Right-sided colon cancer 
 
40 (50%)a 
35 (43.8%)a 
5 (6.3%)a 
Histopathology 
Well-differentiated 
Moderately differentiated 
Poorly differentiated 
 
33 (41.3%)a 
26 (32.5%)a 
21 (26.3%)a 
Haemoglobin  11 (5-19)b 
White blood cells 8850 (1650-25 750)b 
Platelet  32 5178 ± 135 551c 
CEA 6.93(0.42-3340.08)b 
a Categoric data: n (%); b Numeric data, abnormal distribution: median (min-max); c Numeric data, 
normal distribution: mean ± SD. 
 
The correlation between routine blood count 
with CEA is shown in Table 2. Hb, WBC and platelet, 
showed no difference (p > 0.05). 
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Table 2. Correlation of routine blood test with CEA 
Variable 
CEA Levels 
Correlation Coefficient p 
Hb 
WBC 
Platelet 
-0.111 
0.002 
-0.109 
0.32 
0.98 
0.33 
 
 
Table 3 shows a comparison of CEA to tumor 
locations and histopathology grades. Mean of CEA 
level at rectal 223.90 ng/mL, left-sided cancer 156.79 
ng/mL, and right-sided cancer 2.61 ng/mL ng/mL (p = 
0.70). Histopathology examinations showed that there 
were well differentiated 387.66 ng/mL, moderately 
differentiated 36.62 ng/mL and poorly differentiated 
33.90 ng/mL with significant differences among them 
(p = 0.03). 
Table 3. Comparison of carcinoembryonic antigen (CEA) levels 
on histopathology classifications and tumour locations in 
colorectal cancer 
 CEA Level Unit F p 
Tumour location 
Rectal cancer 
Left-sided colon 
Right-sided colon 
 
223.90 ± 741.98 
156.79 ± 378.31 
2.61 ± 0.84 
0.37 0.70 
Histopathology 
Well  
Moderate 
Poorly 
 
387.66 ± 865.33 
36.62 ± 73.50 
33.90 ± 66.22 
 
3.83 
 
0.03 
 
 
 
Discussion 
 
Mostly sample is male (60%). This is 
according to the research of American cancer society 
2012 obtained majority of gender is male than female. 
The localisation a large number of patients had 
colorectal cancer in rectal cancer 50% and Left-sided 
colon cancer 43.8% [10], [11] found that 44 cancers 
were in rectal region and 68 cancers were in other 
regions of the colon.
 
In this study differentiated histopathology 
findings the mostly well-differentiated 41.3%, this is 
similarly from the research of Aru W. Sudoyo et al. 
while the majority of colorectal carcinoma was well-
differentiated [8]. 
CEA is the most widely used tumour marker 
worldwide and certainly the most frequently used 
marker in CRC [9]. In this study, there was a 
significant difference (p = 0.03) mean CEA among 
well differentiated 387.66 ng/ml, moderate 36.62 
ng/ml and poorly 33.90 ng/ml. Well-differentiated CRC 
produces more CEA than poorly differentiated. 
Similarly, CEA tends to be higher in patients with well-
differentiated compared to poorly differentiated [12], 
[13], [14], [15]. Thus, a lack of differentiation or poorly 
differentiated may explain why some patients with 
advanced CRC do not have increased CEA value 
(Park JW et al., 2013). Mean of CEA of location 
tumour obtained CEA increased to rectal cancer 
223.90 and left-sided colon cancer 156.79. Some 
reports suggest that patients with tumours in the left-
sided of colon cancer generally have a higher 
incidence of increased CEA than right-sided of colon 
cancer (Nicholson BD et al., 2015, Jeon BG et al., 
2013) [16], [17].  
In conclusion, CEA levels increased in well-
differentiated colorectal carcinoma especially in rectal 
cancer. 
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